Cardiac Wire #294 August 7, 2025
Lilly Outdoes Itself, Leqvio Monotherapy, and OMRON’s HF Detection
Cardiac Wire #293 August 4, 2025
Pre/Post-CVD Activity, COVID vs. Flu Impact, and Aging Arteries
Cardiac Wire #292 July 31, 2025
AZ’s Anselamimab Hurdle, GDMT for HF, and Roche Cuts CT-173
Cardiac Wire #291 July 28, 2025
SGLT2i Uptake Disparities, The DECIDE Registry, and Unethical Organ Harvesting
Cardiac Wire #290 July 24, 2025
SCCT25’s Top Trends, MI Mix-Ups, and EchoNext
Cardiac Wire #289 July 21, 2025
Polypills’ CVD Potential, Renal Denervation Coverage, and Hypertension in Women
Cardiac Wire #288 July 17, 2025
Kerendia for HF, PREVENT underperforms, and Women’s Hypertension
Cardiac Wire #287 July 14, 2025
CV Deaths Change, SAVR stagnation, and Elderly ACS
Cardiac Wire #286 July 10, 2025
H1 Top 6 Cardiology Trends and More
Cardiac Wire #285 July 3, 2025
Kardium’s PFA Funding, the BABICORN, and the Work Diet
Cardiac Wire #284 June 30, 2025
A Polymer Mitral Valve’s Success and More From NYV 2025
Cardiac Wire #283 June 26, 2025
Microplastics Impact CVD, J&J’s Injunction, and Novo Quits H&H
Cardiac Wire #282 June 23, 2025
Edwards Evoque ADEs, Philips’ Angio Recall, and Baby BP
Cardiac Wire #281 June 19, 2025
Lilly Buys Verve, Cold-Triggered AFib, and GLUCOSE Algorithm
Cardiac Wire #280 June 16, 2025
Abelacimab’s Safety, CABG + Ablation, and UK TAVR Troubles
Cardiac Wire #279 June 12, 2025
BP Triple Polypill, Robot TAVR Explant, and Polymer MV
Cardiac Wire #278 June 9, 2025
Decreasing PCI Contrast, ECG for AS, and The Cost of HF
Cardiac Wire #277 June 5, 2025
Regeneron Buys GLP-1, Titanium Hearts, and Breastfeeding vs. ASCVD
Cardiac Wire #276 June 2, 2025